HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system

被引:49
|
作者
Rutledge, Ronnye [1 ]
Madden, Lynn [2 ,3 ]
Ogbuagu, Onyema [1 ]
Meyer, Jaimie P. [1 ]
机构
[1] Yale Sch Med, Dept Internal Med, Sect Infect Dis, Yale AIDS Program, New Haven, CT 06510 USA
[2] APT Fdn Inc, New Haven, CT USA
[3] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA
关键词
HIV; PrEP; women; criminal justice; probation; risk; PREVENTION; PREP; SEX; MEN; ACCEPTABILITY; PEOPLE; INCARCERATION; WILLINGNESS; POPULATIONS; PREVALENCE;
D O I
10.1080/09540121.2018.1447079
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Women involved in the criminal justice system (WICJ) are at high risk of acquiring HIV and would benefit from HIV pre-exposure prophylaxis (PrEP) but there are no studies in this population to inform PrEP implementation programs. We conducted a cross-sectional survey of HIV-uninfected, cis-gender women on probation, parole and/or recently released from prison/jail to assess PrEP awareness, eligibility, potential barriers to uptake, and the PrEP care continuum. The 125 WICJ surveyed reported high rates of HIV risk behaviors including recent transactional sex (22.4%) and unsafe injection practices (14.4%). Despite 33% (n=42) meeting eligibility criteria for PrEP, only 25% were aware of PrEP and one person was currently using it. Just 16.7% of those who were PrEP eligible perceived they were at risk for HIV. Following a brief explanation of PrEP, 90% said they would try it if recommended by their physician. Compared to those not PrEP eligible (n=83), PrEP eligible women were less likely to be stably housed or have a primary care provider, and were more likely to be violence-exposed, charged with drug possession, have lifetime substance use, or living with Hepatitis C infection. WICJ frequently engage in HIV risk behaviors that make them eligible for PrEP. Uptake may be limited by lack of PrEP awareness or underestimation of personal HIV risk. WICJ report receptiveness to PrEP and represent an important population for targeted PrEP implementation programs.
引用
收藏
页码:1282 / 1289
页数:8
相关论文
共 50 条
  • [41] Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now
    Mofenson, Lynne M.
    PLOS MEDICINE, 2016, 13 (09)
  • [42] Vaginal Bacteria modulate HIV Pre-exposure Prophylaxis Efficacy in Women
    Burgener, Adam D.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 21 - 21
  • [43] Pre-Exposure Prophylaxis for the Primary Prevention of HIV in At-Risk Women: Empowerment and Equity Revisited
    Kofman, Aaron
    Adashi, Eli Y.
    AIDS REVIEWS, 2014, 16 (03) : 134 - 143
  • [44] Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention
    Zhu, Victoria
    Tran, Deanna
    Banjo, Olamide
    Onuegbu, Rosemary
    Seung, Hyunuk
    Layson-Wolf, Cherokee
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (06) : 781 - +
  • [45] Targeted Screening for HIV Pre-Exposure Prophylaxis Eligibility in Two Emergency Departments in Washington, DC
    Kulie, Paige
    Castel, Amanda D.
    Zheng, Zhaonian
    Powell, Natasha N.
    Srivastava, Aneil
    Chandar, Sandhya
    McCarthy, Melissa L.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 516 - 522
  • [46] Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis
    Yoong, Deborah
    Naccarato, Mark
    Sharma, Malika
    Wilton, James
    Senn, Heather
    Tan, Darrell H. S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (08) : 608 - 616
  • [47] HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami
    Doblecki-Lewis, Susanne
    Lester, Larissa
    Schwartz, Bryanna
    Collins, Constance
    Johnson, Rai
    Kobetz, Erin
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (10) : 873 - 881
  • [48] The risk of HIV drug resistance following implementation of pre-exposure prophylaxis
    van de Vijver, David A. M. C.
    Boucher, Charles A. B.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (06) : 621 - 627
  • [49] Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Parya Saberi
    International Journal of Clinical Pharmacy, 2012, 34 : 803 - 806
  • [50] HIV moments and pre-exposure prophylaxis Reply
    Dunn, David T.
    Gafos, Mitzy
    White, Ellen
    McCormack, Sheena
    LANCET, 2016, 387 (10027): : 1508 - 1508